Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer
Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer
Not yet recruiting · NCT07226063 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver cancer, liver disorder, neoplasm | Not yet recruiting | Phase 2 | 2026-05-05 | NCT07226063 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amit Mahipal | 1 |
| Exelixis | 77 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center | Cleveland | United States | 11 |